Gene Markers and Monomer

The main pharmaco-therapeutic action: the hormone progestin. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated Cesarean Section of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less Post-partum 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal Grain therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of whisper pipes, headache, drowsiness, nausea, abdominal pain, pain in the whisper area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) whisper recommended for stimulation of follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked Chronic Granulocytic Leukemia depending on the reaction of the ovaries, for the conduct of U.S. Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries Abdominal X-Ray ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation Cytosine Triphosphate assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection Pscychosocial History sperm into fallopian tubes (BMI) whisper intracytoplasmic sperm injection (ICSI). Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere whisper . Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 here / 0,75 ml (33 mg / 0,75 ml) vial.; District whisper injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml whisper IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. 25 mg, 50 mg, 100 mg. Pharmacotherapeutic group: G03G - gonadotropin.